Alcohol consumption and cardiac biomarkers: The atherosclerosis risk in communities (ARIC) study

Clinical Chemistry

Volumn 62, Issue 9, 2016, Pages 1202-1210

  Lazo, Mariana ^a,b   Chen, Yuan ^b   McEvoy, John W ^a,b   Ndumele, Chiadi ^a,b   Konety, Suma ^c   Ballantyne, Christie M ^d   Sharrett, A Richey ^b   Selvin, Elizabeth ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; TROPONIN T; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HEART STRESS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; DRINKING BEHAVIOR; MIDDLE AGED; PROSPECTIVE STUDY; RISK FACTOR;

ALCOHOL DRINKING; ATHEROSCLEROSIS; BIOMARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; HUMANS; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; RISK FACTORS; TROPONIN T;

EID: 84985896490     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.255778     Document Type: Article

References (36)

1. Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ 2011;342:d671.
2. Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005;365:519-30.
3. McClelland RL, Bild DE, Burke GL, Mukamal KJ, Lima JA, Kronmal RA. Multi-Ethnic Study of Atherosclerosis. Alcohol and coronary artery calcium prevalence, incidence, and progression: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2008;88:1593-601.
4. Demirovic J, Nabulsi A, Folsom AR, Carpenter MA, Szklo M, Sorlie PD, Barnes RW. Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility. The Atherosclerosis Risk In Communities (ARIC) study investigators. Circulation 1993; 88:2787-93.
5. Janszky I, Mukamal KJ, Orth-Gomer K, Romelsjo A, Schenck-Gustafsson K, Svane B, et al. Alcohol consumption and coronary atherosclerosis progression-the stockholm female coronary risk angiographic study. Atherosclerosis 2004;176:311-9.
6. Vliegenthart R, Oei HH, van den Elzen AP, van Rooij FJ, Hofman A, Oudkerk M, Witteman JC. Alcohol consumption and coronary calcification in a general population. Arch Intern Med 2004;164:2355-60.
7. Brien SE, Ronksley PE, Turner BJ, Mukamal KJ, Ghali WA. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ 2011;342:d636.
8. Ballester M, Marti V, Carrio I, Obrador D, Moya C, Pons-Llado G, et al. Spectrum of alcohol-induced myocardial damage detected by indium-111-labeled monoclonal antimyosin antibodies. J Am Coll Cardiol 1997;29: 160-7.
9. Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107-16.
10. Tate JR. Troponin revisited 2008: Assay performance. Clin Chem 2008;46:1489-500.
11. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304: 2503-12.
12. deFilippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, Seliger SL. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 2010;304:2494-502.
13. Saunders JT, Nambi V, de Lemos JA, Chambless LE, Virani SS, Boerwinkle E, et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation 2011; 123:1367-76.
14. Srivastava PK, Pradhan AD, Cook NR, Ridker PM, Everett BM. Impact of modifiable risk factors on B-type natriuretic peptide and cardiac troponin T concentrations. The Am J Cardiol 2016;117:376-81.
15. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
16. Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996;28:22-30.
17. Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, Sutton GC. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53.
18. Bibbins-Domingo K, Gupta R, Na B,WuAH, Schiller NB, Whooley MA. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease. JAMA 2007;297:169-76.
19. Groenning BA, Raymond I, Hildebrandt PR, Nilsson JC, Baumann M, Pedersen F. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart 2004;90:297-303.
20. Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 2005;293:1609-16.
21. Kragelund C, Gronning B, Kober L, Hildebrandt P, Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 2005;352:666-75.
22. Gianoulakis C, Guillaume P, Thavundayil J, Gutkowska J. Increased plasma atrial natriuretic peptide after ingestion of low doses of ethanol in humans. Alcohol Clin Exp Res 1997;21:162-70.
23. Djousse L, Hunt SC, Eckfeldt JH, Arnett DK, Province MA, Ellison RC. Alcohol consumption and plasma atrial natriuretic peptide (from the HyperGEN study). Am J Cardiol 2006;98:628-32.
24. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. The ARIC investigators. AmJ Epidemiol 1989;129:687-702.
25. Volcik KA, Ballantyne CM, Fuchs FD, Sharrett AR, Boerwinkle E. Relationship of alcohol consumption and type of alcoholic beverage consumed with plasma lipid levels: differences between Whites and African Americans of the ARIC study. Ann Epidemiol 2008;18:101-7.
26. Parrinello CM, Grams ME, Couper D, Ballantyne CM, Hoogeveen RC, Eckfeldt JH, et al. Calibration of analytes over twenty-five years in the atherosclerosis risk in communities study. American Heart Association Epidemiology and Prevention and Nutrition, Physical Activity and Metabolism 2014 Scientific Sessions, 2014 March 18-21; San Francisco, CA, 2014.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
28. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-12.
29. Januzzi JL, van Kimmenade R, Lainchbury J, Bayes-Genis A, Ordonez-Llanos J, Santalo-Bel M, et al. NTproBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur Heart J 2006;27: 330-7.
30. Blaha MJ, Cainzos-Achirica M, Greenland P, McEvoy JW, Blankstein R, Budoff MJ, et al. Role of coronary artery calcium score of zero and other negative risk markers for cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation 2016;133: 849-58.
31. Harrell F. Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. New York, NY, Springer, 2001.
32. Djousse L, Gaziano JM. Alcohol consumption and heart failure: a systematic review. Curr Atheroscler Rep 2008; 10:117-20.
33. Bower JK, Lazo M, Matsushita K, Rubin J, Hoogeveen RC, Ballantyne CM, Selvin E. N-terminal pro-brain natriuretic peptide (NT-proBNP) and risk of hypertension in the Atherosclerosis Risk in Communities (ARIC) study. Am J Hypertens 2015;28:1262-6.
34. Cushman M, Judd SE, Howard VJ, Kissela B, Gutierrez OM, Jenny NS, et al. N-terminal pro-B-type natriuretic peptide and stroke risk: the reasons for geographic and racial differences in stroke cohort. Stroke 2014;45: 1646-50.
35. Folsom AR, Nambi V, Bell EJ, Oluleye OW, Gottesman RF, Lutsey PL, et al. Troponin T, N-terminal pro-B-type natriuretic peptide, and incidence of stroke: the atherosclerosis risk in communities study. Stroke 2013;44: 961-7.
36. Fuchs FD, Chambless LE, Whelton PK, Nieto FJ, Heiss G. Alcohol consumption and the incidence of hypertension: the Atherosclerosis Risk in Communities Study. Hypertension 2001;37:1242-50.